JULY 2026
The Heart Rhythm Center scientific team has achieved a significant clinical milestone by successfully performing the first atrial fibrillation (AF) ablation procedures in Greece utilizing Abbott’s innovative TactiFlex™ Duo Dual-Energy Ablation System.
This cutting-edge technology enables the combined or selective delivery of both radiofrequency (RF) and pulsed-field ablation (PFA) energy through a single catheter platform. The integration of the TactiFlex™ Duo system introduces unprecedented versatility, speed, and precision to pulmonary vein isolation (PVI), ensuring optimal tissue contact and significantly reducing procedural duration while maximizing patient safety. The excellent clinical outcomes achieved in these initial cases confirm the platform’s reliability and mark a new era in the tailored management of complex cardiac arrhythmias.
The procedures were successfully executed through the seamless collaboration of our center’s physicians and associates, under the leadership of the Director of the Heart Rhythm Center, P. Ioannidis. Additionally, the clinical and technical support provided by Abbott’s representatives was instrumental, securing yet another significant scientific standing for our department at a national level.
